Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Colombel

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
European Radiology|January 10, 2022
Combined model-based and deep learning-based automated 3D zonal segmentation of the prostate on T2-weighted MR images: clinical evaluationOlivier Rouvière, Paul Cezar Moldovan, Anna Vlachomitrou, et al.
Cancer|October 18, 2007
Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinomaGeorg C Hutterer, Jean-Jacques Patard, Marc Colombel, et al.
Radiology|January 24, 2018
Characterization of Prostate Cancer with Gleason Score of at Least 7 by Using Quantitative Multiparametric MR Imaging: Validation of a Computer-aided Diagnosis System in Patients Referred for Prostate BiopsyAu Hoang Dinh, Christelle Melodelima, Rémi Souchon, et al.
World Journal of Urology|October 16, 2023
Zone-specific computer-aided diagnosis system aimed at characterizing ISUP ≥ 2 prostate cancers on multiparametric magnetic resonance images: evaluation in a cohort of patients on active surveillanceThéo Arber, Tristan Jaouen, Séphora Campoy, et al.
BJU International|January 18, 2020
Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)Justin T Matulay, Mark Soloway, J Alfred Witjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer GroupAshish M Kamat, Richard J Sylvester, Andreas Böhle, et al.
Radiology|April 13, 2013
Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter studyPhilippe Puech, Olivier Rouvière, Raphaele Renard-Penna, et al.
Microbial Cell (Graz, Austria)|June 5, 2023
TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterizationSylvain Thierry, Sarah Maadadi, Aurore Berton, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
European Radiology|January 10, 2022
Combined model-based and deep learning-based automated 3D zonal segmentation of the prostate on T2-weighted MR images: clinical evaluationOlivier Rouvière, Paul Cezar Moldovan, Anna Vlachomitrou, et al.
Cancer|October 18, 2007
Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinomaGeorg C Hutterer, Jean-Jacques Patard, Marc Colombel, et al.
Radiology|January 24, 2018
Characterization of Prostate Cancer with Gleason Score of at Least 7 by Using Quantitative Multiparametric MR Imaging: Validation of a Computer-aided Diagnosis System in Patients Referred for Prostate BiopsyAu Hoang Dinh, Christelle Melodelima, Rémi Souchon, et al.
World Journal of Urology|October 16, 2023
Zone-specific computer-aided diagnosis system aimed at characterizing ISUP ≥ 2 prostate cancers on multiparametric magnetic resonance images: evaluation in a cohort of patients on active surveillanceThéo Arber, Tristan Jaouen, Séphora Campoy, et al.
BJU International|January 18, 2020
Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)Justin T Matulay, Mark Soloway, J Alfred Witjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer GroupAshish M Kamat, Richard J Sylvester, Andreas Böhle, et al.
Radiology|April 13, 2013
Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter studyPhilippe Puech, Olivier Rouvière, Raphaele Renard-Penna, et al.
Microbial Cell (Graz, Austria)|June 5, 2023
TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterizationSylvain Thierry, Sarah Maadadi, Aurore Berton, et al.
Pageof 12